Literature DB >> 19807349

Methodological issues in the monetary valuation of benefits in healthcare.

Mandy Ryan1, Verity Watson, Mabelle Amaya-Amaya.   

Abstract

Economic evaluation is concerned with comparing the costs and benefits of competing healthcare interventions in order to efficiently allocate resources. Whilst valuing costs is important, the valuation of benefits represents one of the greatest challenges facing health economists. This review considers the different techniques available for the valuation of healthcare benefits in monetary terms, and more specifically the contingent valuation method and discrete choice experiments. This review identifies some of the key issues and debates that have been published in the literature concerning the application of the techniques to healthcare and highlights important areas for future research.

Year:  2003        PMID: 19807349     DOI: 10.1586/14737167.3.6.717

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  10 in total

1.  Discrete choice experiments in health care.

Authors:  Mandy Ryan
Journal:  BMJ       Date:  2004-02-14

2.  Valuing Healthcare Goods and Services: A Systematic Review and Meta-Analysis on the WTA-WTP Disparity.

Authors:  Adriënne H Rotteveel; Mattijs S Lambooij; Nicolaas P A Zuithoff; Job van Exel; Karel G M Moons; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2020-05       Impact factor: 4.981

3.  Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment.

Authors:  Nina Lathia; Pierre K Isogai; Scott E Walker; Carlo De Angelis; Matthew C Cheung; Jeffrey S Hoch; Nicole Mittmann
Journal:  Support Care Cancer       Date:  2012-06-09       Impact factor: 3.603

4.  Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis.

Authors:  Ilene L Hollin; Holly L Peay; John F P Bridges
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

5.  Quality versus quantity in end-of-life choices of cancer patients and support persons: a discrete choice experiment.

Authors:  Amy Waller; Rob Sanson-Fisher; Scott D Brown; Laura Wall; Justin Walsh
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

6.  A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services.

Authors:  S Peacock; C Apicella; L Andrews; K Tucker; A Bankier; M B Daly; J L Hopper
Journal:  Br J Cancer       Date:  2006-11-20       Impact factor: 7.640

7.  A pragmatic, multicentre, randomised controlled trial comparing stapled haemorrhoidopexy to traditional excisional surgery for haemorrhoidal disease (eTHoS): study protocol for a randomised controlled trial.

Authors:  Angus J M Watson; Hanne Bruhn; Kathleen MacLeod; Alison McDonald; Gladys McPherson; Mary Kilonzo; John Norrie; Malcolm A Loudon; Kirsty McCormack; Brian Buckley; Steven Brown; Finlay Curran; David Jayne; Ramesh Rajagopal; Jonathan A Cook
Journal:  Trials       Date:  2014-11-11       Impact factor: 2.279

8.  The SIMS trial: adjustable anchored single-incision mini-slings versus standard tension-free midurethral slings in the surgical management of female stress urinary incontinence. A study protocol for a pragmatic, multicentre, non-inferiority randomised controlled trial.

Authors:  Mohamed Abdel-Fattah; Graeme MacLennan; Mary Kilonzo; R Phil Assassa; Kirsty McCormick; Tracey Davidson; Alison McDonald; James N'Dow; Judith Wardle; John Norrie
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

Review 9.  Health economic assessment: a methodological primer.

Authors:  Steven Simoens
Journal:  Int J Environ Res Public Health       Date:  2009-11-27       Impact factor: 3.390

Review 10.  Democracy, Culture and Cancer Patients' Willingness to Pay for Healthcare Services: A Meta-analysis.

Authors:  Mayula Chaikumbung
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 2.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.